Research News

LSUHS Pandemic Response

LSU Health Shreveport has been on the front line fighting the COVID-19 pandemic since the beginning. The establishment of the Emerging Viral Threats lab in March of 2020 led to mass testing and vaccination sites, clinical trials in patient treatment options and viral sequencing that discovered 7 COVID-19. variants.

Read More about LSUHS Pandemic Response
Delta’s highly infectious nature positions it to outcompete new variants, scientists say

Wall Street Journal - Some virologists believe the Delta variant evolved to maximize transmissibility and that its ability to spread rapidly will eventually reach a ceiling as more of the global population gets vaccinated. “It looks like this virus is already driving a Lamborghini right now in terms of transmissibility, so I’m not sure it can get much faster,” said Jeremy Kamil, a virologist at LSU Health Shreveport who is studying coronavirus genetics. Read the full article.

Read More about Delta’s highly infectious nature positions it to outcompete new variants, scientists say (opens in new window/tab)
LSUHS Postdoctoral Fellow receives Award from American Heart Association

Mabruka Alfaidi, PhD, Postdoctoral Fellow in Pathology at LSU Health Shreveport, has been selected as a recipient of an American Heart Association Career Development Award. This prestigious award supports highly promising healthcare and academic professionals in the early years of their career by funding innovative research and training to assure the future success of the awardee as a cardiovascular independent scientist.

Read More about LSUHS Postdoctoral Fellow receives Award from American Heart Association
LSU Health Shreveport post-doctoral fellow receives Career Development Award from American Heart Association

BIZ Magazine - Celeste Y.C. Wu, PhD, post-doctoral fellow in the Department of Neurology at LSU Health Shreveport, was awarded the American Heart Association Career Development Award receiving $231,000 in funding.

Read More about LSU Health Shreveport post-doctoral fellow receives Career Development Award from American Heart Association (opens in new window/tab)
Nicholas Goeders, PhD, LSUHS faculty and internationally renowned expert, appointed to JanOne Scientific Advisory Board

PRNewswire — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world’s leaders on the role of stress in drug addiction.

Read More about Nicholas Goeders, PhD, LSUHS faculty and internationally renowned expert, appointed to JanOne Scientific Advisory Board
LSU Health Shreveport receives grant for global response to pandemic threats

Louisiana Radio Network - The objective of the grant is to strengthen global capabilities to detect and respond to pandemic threats in the future. Director for Emerging Viral Threats at LSUHS Dr. Andrew Yurochko said the award is indicative of LSU Health Shreveport’s strides in detecting variants and assisting with vaccine rollout.

Read More about LSU Health Shreveport receives grant for global response to pandemic threats (opens in new window/tab)
LSU Health Shreveport Receives $730,000 in NIH Funding for Sequencing of COVID-19

Red River Radio - Work by Drs. Jeremy Kamil and Rona Scott along with COBRE principal investigators Drs. Andrew Yurochko and Chris Kevil has produced and shared 2,839 full coverage SARS-CoV-2 genomes, which amounts to over 60% of the SARSCoV-2 genome surveillance from Louisiana, and 1.2 % of the total US data submitted to GISAID which is the Global Initiative on Sharing All Influenza Data.

Read More about LSU Health Shreveport Receives $730,000 in NIH Funding for Sequencing of COVID-19 (opens in new window/tab)
Rockefeller Foundation announces grant funding to LSUHS to build coalition to detect and respond to pandemic threats

The Rockefeller Foundation - LSU Health Shreveport (LSUHS) is receiving funding ($340,000) from the Rockefeller Foundation. This follows the announcement yesterday of LSUHS being awarded $730,000 to further its work in genomic sequencing of COVID-19 through a NIH supplemental grant.  LSUHS joins Harvard and the Broad Institute at MIT among others in the US Regional Accelerators for Genomic Surveillance.

Read More about Rockefeller Foundation announces grant funding to LSUHS to build coalition to detect and respond to pandemic threats
LSU Health Shreveport detects first reported B.1.617.2 (Indian) COVID-19 variant in Louisiana

LSU Health Shreveport has identified two cases of the novel COVID-19 variant of concern, B.1.617.2, which was first identified in India and is rapidly spreading around the world. LSU Health Shreveport sequencing also reveals that B.1.1.7, sometimes called “the U.K. variant,” remains dominant in North Louisiana, as is the case in the rest of the United States, as well. 

Read More about LSU Health Shreveport detects first reported B.1.617.2 (Indian) COVID-19 variant in Louisiana